Literature DB >> 33665186

Applying Stretch to Evoke Hyperreflexia in Spasticity Testing: Velocity vs. Acceleration.

Lizeth H Sloot1,2, Guido Weide1,3, Marjolein M van der Krogt1, Kaat Desloovere3, Jaap Harlaar1,4, Annemieke I Buizer1,5, Lynn Bar-On1,3.   

Abstract

In neurological diseases, muscles often become hyper-resistant to stretch due to hyperreflexia, an exaggerated stretch reflex response that is considered to primarily depend on the muscle's stretch velocity. However, there is still limited understanding of how different biomechanical triggers applied during clinical tests evoke these reflex responses. We examined the effect of imposing a rotation with increasing velocity vs. increasing acceleration on triceps surae muscle repsonse in children with spastic paresis (SP) and compared the responses to those measured in typically developing (TD) children. A motor-operated ankle manipulator was used to apply different bell-shaped movement profiles, with three levels of maximum velocity (70, 110, and 150°/s) and three levels of maximum acceleration (500, 750, and 1,000°/s2). For each profile and both groups, we evaluated the amount of evoked triceps surae muscle activation. In SP, we evaluated two additional characteristics: the intensity of the response (peak EMG burst) and the time from movement initiation to onset of the EMG burst. As expected, the amount of evoked muscle activation was larger in SP compared to TD (all muscles: p < 0.001) and only sensitive to biomechanical triggers in SP. Further investigation of the responses in SP showed that peak EMG bursts increased in profiles with higher peak velocity (lateral gastrocnemius: p = 0.04), which was emphasized by fair correlations with increased velocity at EMG burst onset (all muscles: r > 0.33-0.36, p ≤ 0.008), but showed no significant effect for acceleration. However, the EMG burst was evoked faster with higher peak acceleration (all muscles p < 0.001) whereas it was delayed in profiles with higher peak velocity (medial gastrocnemius and soleus: p < 0.006). We conclude that while exaggerated response intensity (peak EMG burst) seems linked to stretch velocity, higher accelerations seem to evoke faster responses (time to EMG burst onset) in triceps surae muscles in SP. Understanding and controlling for the distinct effects of different biological triggers, including velocity, acceleration but also length and force of the applied movement, will contribute to the development of more precise clinical measurement tools. This is especially important when aiming to understand the role of hyperreflexia during functional movements where the biomechanical inputs are multiple and changing.
Copyright © 2021 Sloot, Weide, van der Krogt, Desloovere, Harlaar, Buizer and Bar-On.

Entities:  

Keywords:  cerebral palsy; hyperreflexia; spastic paresis; spasticity assessment; stretch reflex; upper motor neuron

Year:  2021        PMID: 33665186      PMCID: PMC7921693          DOI: 10.3389/fbioe.2020.591004

Source DB:  PubMed          Journal:  Front Bioeng Biotechnol        ISSN: 2296-4185


  35 in total

1.  Development of recommendations for SEMG sensors and sensor placement procedures.

Authors:  H J Hermens; B Freriks; C Disselhorst-Klug; G Rau
Journal:  J Electromyogr Kinesiol       Date:  2000-10       Impact factor: 2.368

2.  Test-retest reliability of isokinetic dynamometry for the assessment of spasticity of the knee flexors and knee extensors in children with cerebral palsy.

Authors:  Samuel R Pierce; Richard T Lauer; Patricia A Shewokis; Joseph A Rubertone; Margo N Orlin
Journal:  Arch Phys Med Rehabil       Date:  2006-05       Impact factor: 3.966

Review 3.  Theoretical and methodological considerations in the measurement of spasticity.

Authors:  J H Burridge; D E Wood; H J Hermens; G E Voerman; G R Johnson; F van Wijck; T Platz; M Gregoric; R Hitchcock; A D Pandyan
Journal:  Disabil Rehabil       Date:  2005 Jan 7-21       Impact factor: 3.033

4.  Sensory feedback to ankle plantar flexors is not exaggerated during gait in spastic hemiplegic children with cerebral palsy.

Authors:  Maria Willerslev-Olsen; Jacob Buus Andersen; Thomas Sinkjaer; Jens Bo Nielsen
Journal:  J Neurophysiol       Date:  2013-11-13       Impact factor: 2.714

5.  European consensus on the concepts and measurement of the pathophysiological neuromuscular responses to passive muscle stretch.

Authors:  J C van den Noort; L Bar-On; E Aertbeliën; M Bonikowski; S M Braendvik; E W Broström; A I Buizer; J H Burridge; A van Campenhout; B Dan; J F Fleuren; S Grunt; F Heinen; H L Horemans; C Jansen; A Kranzl; B K Krautwurst; M van der Krogt; S Lerma Lara; C M Lidbeck; J-P Lin; I Martinez; C Meskers; D Metaxiotis; G Molenaers; D A Patikas; O Rémy-Néris; K Roeleveld; A P Shortland; J Sikkens; L Sloot; R J Vermeulen; C Wimmer; A S Schröder; S Schless; J G Becher; K Desloovere; J Harlaar
Journal:  Eur J Neurol       Date:  2017-05-29       Impact factor: 6.089

6.  Stretch reflex dynamics in spastic elbow flexor muscles.

Authors:  R K Powers; D L Campbell; W Z Rymer
Journal:  Ann Neurol       Date:  1989-01       Impact factor: 10.422

7.  Muscle stiffness in human ankle dorsiflexors: intrinsic and reflex components.

Authors:  T Sinkjaer; E Toft; S Andreassen; B C Hornemann
Journal:  J Neurophysiol       Date:  1988-09       Impact factor: 2.714

Review 8.  Spastic movement disorder: impaired reflex function and altered muscle mechanics.

Authors:  Volker Dietz; Thomas Sinkjaer
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

9.  Differentiation between non-neural and neural contributors to ankle joint stiffness in cerebral palsy.

Authors:  Karin L de Gooijer-van de Groep; Erwin de Vlugt; Jurriaan H de Groot; Hélène C M van der Heijden-Maessen; Dennis H M Wielheesen; Rietje M S van Wijlen-Hempel; J Hans Arendzen; Carel G M Meskers
Journal:  J Neuroeng Rehabil       Date:  2013-07-23       Impact factor: 4.262

Review 10.  Spasticity and its contribution to hypertonia in cerebral palsy.

Authors:  Lynn Bar-On; Guy Molenaers; Erwin Aertbeliën; Anja Van Campenhout; Hilde Feys; Bart Nuttin; Kaat Desloovere
Journal:  Biomed Res Int       Date:  2015-01-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.